Arzeda Corporation
Computational protein design company creating custom enzymes and proteins for pharmaceutical, industrial, and agricultural applications using AI-powered design technology.
Notes
Arzeda Corporation is a computational protein design company that uses AI and computational biology to create custom proteins and enzymes for a wide range of applications. Founded by pioneers in computational protein design from the University of Washington, including collaborators of Nobel Prize-winning scientist David Baker, Arzeda has developed a proprietary platform for designing proteins with novel functions.
The company's technology platform enables the de novo design of proteins that don't exist in nature, optimized for specific applications in pharmaceuticals, industrial chemistry, agriculture, and materials. Arzeda's designed proteins are used in manufacturing processes, as therapeutic candidates, and as tools for various industrial applications.
Arzeda is backed by Sofinnova Partners and other leading life sciences investors.
Team
- Alexandre Zanghellini, Ph.D. - Co-founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/azanghellini
- David Baker, Ph.D. - Scientific Co-founder
- University of Washington Professor, 2024 Nobel Prize in Chemistry
- Eric Althoff, Ph.D. - Co-founder & Chief Technology Officer
- LinkedIn: linkedin.com/in/ericalthoff
Additional Research Findings
- Portfolio company of Sofinnova Partners
- Computational protein design platform
- Scientific co-founder David Baker won 2024 Nobel Prize in Chemistry
- Applications in pharma, industrial, and agricultural sectors
- AI-powered protein design technology
- Seattle, Washington headquarters
- De novo enzyme design capabilities
- Founded 2008
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |